Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Sep 21;161(6):699–704.

Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995

H K Wolf 1, P Andreou 1, I R Bata 1, D G Comeau 1, R D Gregor 1, G Kephart 1, D R MacLean 1, I Sketris 1
PMCID: PMC1230618  PMID: 10513276

Abstract

BACKGROUND: The objective of this study was to document changes in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995 in an effort to observe, at the population level, the consequences of the availability of new antihypertensive medications. METHODS: The study population comprised a random sample of Halifax County residents, aged 25-64 years, who responded to the 1985 and 1995 surveys of the Halifax County MONICA Project and residents who responded to the Nova Scotia Health Survey conducted in 1995. Data from the two 1995 surveys were pooled. Information on hypertension awareness and use of medication were obtained through questionnaires, and blood pressure was measured according to a standard protocol, using phase I and V of Korotkoff sounds as respective markers for systolic and diastolic pressures. Uncontrolled hypertension was defined as a systolic pressure of 140 mm Hg or greater and a diastolic pressure of 90 mm Hg or greater. Changes in the prevalence of hypertension, prescribing trends and medication costs were examined, and the association between the type of antihypertensive treatment and characteristics of the respondents with self-reported hypertension was investigated by multivariate logistic regression. RESULTS: Of the 917 people interviewed in 1985 and the 1338 in 1995, 274 (29.9%) and 356 (26.6%), respectively, reported a history of hypertension. When age was controlled for, the proportion of respondents reporting hypertension did not differ between survey years or between men and women. The proportion of treated respondents who had uncontrolled hypertension increased between 1985 and 1995, from 32.6% to 57.4% among men and from 38.0% to 42.6% among women. An increase was seen in the use of calcium-channel blockers (from 2.1% to 19.7%) and angiotensin-converting-enzyme inhibitors (from 5.2% to 25.4%); the proportion of patients receiving combination therapy or diuretics decreased (from 39.6% to 15.6% and from 31.3% to 17.2% respectively). These changes were associated with an increase in the average daily cost of medication from $0.48 to $0.85 per patient. INTERPRETATION: The shift to new antihypertensive drugs was not associated with improved blood pressure control, but it was associated with an increase in average medication costs per patient. Uncontrolled hypertension remains a public health problem.

Full Text

The Full Text of this article is available as a PDF (216.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett S. Cardiovascular risk factors in Australia: trends in socioeconomic inequalities. J Epidemiol Community Health. 1995 Aug;49(4):363–372. doi: 10.1136/jech.49.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Birkett N. J. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens. 1997 Mar;15(3):237–244. doi: 10.1097/00004872-199715030-00004. [DOI] [PubMed] [Google Scholar]
  3. Burt V. L., Whelton P., Roccella E. J., Brown C., Cutler J. A., Higgins M., Horan M. J., Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995 Mar;25(3):305–313. doi: 10.1161/01.hyp.25.3.305. [DOI] [PubMed] [Google Scholar]
  4. Clark L. T. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991 Feb;121(2 Pt 2):664–669. doi: 10.1016/0002-8703(91)90443-l. [DOI] [PubMed] [Google Scholar]
  5. Eastwood B. J., Gregor R. D., MacLean D. R., Wolf H. K. Effects of recruitment strategy on response rates and risk factor profile in two cardiovascular surveys. Int J Epidemiol. 1996 Aug;25(4):763–769. doi: 10.1093/ije/25.4.763. [DOI] [PubMed] [Google Scholar]
  6. Glynn R. J., Brock D. B., Harris T., Havlik R. J., Chrischilles E. A., Ostfeld A. M., Taylor J. O., Hennekens C. H. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med. 1995 Sep 25;155(17):1855–1860. [PubMed] [Google Scholar]
  7. Gregor R. D., Bata I. R., Eastwood B. J., Wolf H. K. Ten-year trends of heart disease risk factors in the Halifax County MONICA population. MONItoring of trends and determinants in CArdiovascular disease. Can J Cardiol. 1998 Aug;14(8):1017–1024. [PubMed] [Google Scholar]
  8. Gross T. P., Wise R. P., Knapp D. E. Antihypertensive drug use. Trends in the United States from 1973 to 1985. Hypertension. 1989 May;13(5 Suppl):I113–I118. doi: 10.1161/01.hyp.13.5_suppl.i113. [DOI] [PubMed] [Google Scholar]
  9. Hense H. W., Koivisto A. M., Kuulasmaa K., Zaborskis A., Kupsc W., Tuomilehto J. Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA project. J Hum Hypertens. 1995 Dec;9(12):935–946. [PubMed] [Google Scholar]
  10. Hoffmeister H., Mensink G. B., Stolzenberg H. National trends in risk factors for cardiovascular disease in Germany. Prev Med. 1994 Mar;23(2):197–205. doi: 10.1006/pmed.1994.1027. [DOI] [PubMed] [Google Scholar]
  11. Hosie J., Wiklund I. Managing hypertension in general practice: can we do better? J Hum Hypertens. 1995 Jul;9 (Suppl 2):S15–S18. [PubMed] [Google Scholar]
  12. Hume A. L., Barbour M. M., Willey C. J., Assaf A. R., Lapane K. L., Carleton R. A. Changing trends in antihypertensive therapy in two New England communities during the 1980s. Pharmacotherapy. 1993 May-Jun;13(3):244–251. [PubMed] [Google Scholar]
  13. Jackson R., Yee R. L., Priest P., Shaw L., Beaglehole R. Trends in coronary heart disease risk factors in Auckland 1982-94. N Z Med J. 1995 Nov 10;108(1011):451–454. [PubMed] [Google Scholar]
  14. Joffres M. R., Ghadirian P., Fodor J. G., Petrasovits A., Chockalingam A., Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997 Oct;10(10 Pt 1):1097–1102. doi: 10.1016/s0895-7061(97)00224-0. [DOI] [PubMed] [Google Scholar]
  15. Kastarinen M. J., Salomaa V. V., Vartiainen E. A., Jousilahti P. J., Tuomilehto J. O., Puska P. M., Nissinen A. M. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens. 1998 Sep;16(9):1379–1387. doi: 10.1097/00004872-199816090-00019. [DOI] [PubMed] [Google Scholar]
  16. Laplante P., Niyonsenga T., Delisle E., Vanasse N., Vanasse A., Grant A. M., Xhignesse M. Habitudes de traitement de l'hypertension en 1996. Données du registre québécois FAMUS. Can Fam Physician. 1998 Feb;44:306–312. [PMC free article] [PubMed] [Google Scholar]
  17. Logan A. G. Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension. Can Med Assoc J. 1984 Nov 1;131(9):1053–1057. [PMC free article] [PubMed] [Google Scholar]
  18. Luepker R. V., Rosamond W. D., Murphy R., Sprafka J. M., Folsom A. R., McGovern P. G., Blackburn H. Socioeconomic status and coronary heart disease risk factor trends. The Minnesota Heart Survey. Circulation. 1993 Nov;88(5 Pt 1):2172–2179. doi: 10.1161/01.cir.88.5.2172. [DOI] [PubMed] [Google Scholar]
  19. Manolio T. A., Cutler J. A., Furberg C. D., Psaty B. M., Whelton P. K., Applegate W. B. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995 Apr 24;155(8):829–837. [PubMed] [Google Scholar]
  20. McAlister F. A., Teo K. K., Lewanczuk R. Z., Wells G., Montague T. J. Contemporary practice patterns in the management of newly diagnosed hypertension. CMAJ. 1997 Jul 1;157(1):23–30. [PMC free article] [PubMed] [Google Scholar]
  21. Myers M. G., Carruthers S. G., Leenen F. H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ. 1989 May 15;140(10):1141–1146. [PMC free article] [PubMed] [Google Scholar]
  22. Penrose A., Dovey S., Tilyard M. Trends in antihypertensive prescribing. N Z Med J. 1996 Jan 26;109(1014):4–7. [PubMed] [Google Scholar]
  23. Schueler K. Cost-effectiveness issues in hypertension control. Can J Public Health. 1994 Sep-Oct;85 (Suppl 2):S54–S56. [PubMed] [Google Scholar]
  24. Yasin S. Detecting and improving compliance. Is concordance the solution? Aust Fam Physician. 1998 Apr;27(4):255–260. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES